• 1. Dissolved oxygen sensor based on fluorescence quenching of oxygen-sensitive ruthenium complexes immobilized in sol–gel-derived porous silica coatings
  Analyst, 1996,121, 785-788
• 2. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555
• 3. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 4. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538
• 5. Fe/Fe3C@C nanoparticles encapsulated in N-doped graphene–CNTs framework as an efficient bifunctional oxygen electrocatalyst for robust rechargeable Zn–air batteries?
  Zhiyan Chen,Nan Wu,Yaobing Wang,Bing Wang,Yingde Wang J. Mater. Chem. A, 2018,6, 516-526

Carbamic acid, N-(3-cyclobutyl-1-ethyl-3-oxopropyl)-, 1,1-dimethylethyl ester (CAS No. 1857094-22-4): A Comprehensive Overview

Carbamic acid, N-(3-cyclobutyl-1-ethyl-3-oxopropyl)-, 1,1-dimethylethyl ester, identified by its CAS number 1857094-22-4, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical and chemical research. This compound belongs to the class of carbamates, which are widely recognized for their versatile applications in medicinal chemistry and agrochemicals. The unique structural features of this molecule, including its cyclobutyl and ethyl substituents, contribute to its distinct chemical properties and potential biological activities.

The< strong>structure of Carbamic acid, N-(3-cyclobutyl-1-ethyl-3-oxopropyl)-, 1,1-dimethylethyl ester consists of a carbamate functional group attached to a propyl chain that is further substituted with a cyclobutyl ring and an ethyl group. The presence of the 1,1-dimethylethyl (tert-butyl) group enhances the stability of the molecule, making it a valuable intermediate in synthetic chemistry. This compound's complexity and functionality have positioned it as a subject of interest in various research endeavors.

In recent years, there has been growing interest in the development of novel carbamate-based compounds due to their potential therapeutic applications. Carbamates are known for their ability to act as intermediates in the synthesis of various pharmacologically active agents. The< strong>cyclobutyl moiety in Carbamic acid, N-(3-cyclobutyl-1-ethyl-3-oxopropyl)-, 1,1-dimethylethyl ester introduces steric hindrance, which can influence the compound's interactions with biological targets. This feature is particularly relevant in drug design, where precise control over molecular interactions is crucial for achieving desired pharmacological effects.

One of the most compelling aspects of this compound is its potential role in the development of new drugs. Researchers have been exploring the< strong>biological activity of carbamate derivatives to identify compounds with therapeutic potential. The< strong>N-(3-cyclobutyl-1-ethyl-3-oxopropyl) substituent may contribute to unique binding properties that could be exploited in drug design. For instance, studies have shown that carbamates can interact with enzymes and receptors in ways that other classes of compounds cannot. This makes them attractive candidates for developing drugs with novel mechanisms of action.

The< strong>synthetic utility of Carbamic acid, N-(3-cyclobutyl-1-ethyl-3-oxopropyl)-, 1,1-dimethylethyl ester is another area of significant interest. The compound can serve as a building block for more complex molecules, enabling chemists to construct intricate structures with desired properties. In pharmaceutical research, such intermediates are invaluable for generating libraries of compounds that can be screened for biological activity. The ability to modify the< strong>cyclobutyl and< strong>ethyl groups allows for fine-tuning of the molecule's characteristics, making it adaptable to various synthetic strategies.

In addition to its pharmaceutical applications, this compound has potential uses in other areas of chemistry. For example, it can be employed in the synthesis of specialty chemicals and materials where its unique structural features are beneficial. The< strong>stability provided by the 1,1-dimethylethyl group makes it a reliable intermediate that can withstand harsh reaction conditions without degradation.

The< strong>CAS number 1857094-22-4 provides a unique identifier for this compound, facilitating its recognition and use in scientific literature and databases. This standardized naming system ensures that researchers around the world can accurately reference and utilize this compound in their work. The CAS registry number is particularly important in ensuring consistency across different studies and publications.

The study of carbamates like Carbamic acid, N-(3-cyclobutyl-1-ethyl-3-oxopropyl)-, 1,1-dimethylethyl ester continues to evolve with advancements in synthetic chemistry and computational methods. Researchers are increasingly leveraging computational tools to predict the properties and reactivities of these compounds before they are synthesized in the laboratory. This approach not only saves time but also reduces the environmental impact associated with trial-and-error experimentation.

In conclusion, Carbamic acid, N-(3-cyclobutulystereochemistryethyl)-ester (CAS No. 1857094224) is a multifaceted compound with significant potential in pharmaceutical research and chemical synthesis. Its unique structural features make it a valuable intermediate for developing new drugs and specialty chemicals. As research progresses，the applications and understanding of this compound are likely to expand，further highlighting its importance in the chemical community.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)